ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for charts 登録してリアルタイムのチャート、分析ツール、価格を入手してください。

VIGL Vigil Neuroscience Inc

4.20
-0.17 (-3.89%)
2024年6月15日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Vigil Neuroscience Inc VIGL NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
-0.17 -3.89% 4.20 13:00:07
始値 安値 高値 終値 前日終値
4.26 4.02 4.42 4.33 4.37
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/6/0806:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0806:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/6/0705:05EDGAR2Form 8-K - Current report
2024/5/3020:05GLOBEVigil Neuroscience to Present in Upcoming June Investor..
2024/5/0820:40GLOBEVigil Neuroscience to Present at The Citizens JMP Life..
2024/5/0806:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/0806:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/0806:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/0806:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/0805:35EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/0805:20EDGAR2Form 8-K - Current report
2024/5/0805:05GLOBEVigil Neuroscience Reports First Quarter 2024 Financial..
2024/4/1805:05GLOBEVigil Presents Key Findings from ILLUMINATE & IGNITE Studies..
2024/3/2620:05GLOBEVigil Neuroscience Reports Fourth Quarter and Full Year 2023..
2024/3/2020:05GLOBEVigil Neuroscience Appoints Petra Kaufmann, M.D., as Chief..
2024/3/1320:05GLOBEVigil Announces Upcoming Presentations at 2024 American..
2024/3/1220:05GLOBEVigil Neuroscience to Present at Stifel 2024 Virtual CNS..
2024/3/0706:25GLOBEVigil Announces Oral Presentation on Small Molecule TREM2..
2024/3/0208:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0207:50EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0106:05GLOBEVigil Presents Poster on Impacts of Misdiagnosis and Genetic..
2024/2/1501:33EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0806:05GLOBEVigil Neuroscience to Present at Guggenheim 6th Annual..
2024/1/1200:30EDGAR2Form 8-K - Current report
2024/1/0406:30GLOBEVigil Neuroscience Provides 2023 Year-in-Review and..
2023/11/2306:05GLOBEVigil Neuroscience to Present at Evercore ISI 6th Annual..
2023/11/1706:31EDGAR2Form 8-K - Current report
2023/11/1706:05GLOBEVigil Neuroscience Reports Positive Interim Data from Phase..
2023/11/0721:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/0721:15EDGAR2Form 8-K - Current report
2023/11/0721:05GLOBEVigil Neuroscience Reports Third Quarter 2023 Financial..
2023/10/1720:05GLOBEVigil Neuroscience Announces First Participant Dosed in..
2023/10/1305:06EDGAR2Form 8-K - Current report
2023/10/0605:01GLOBEVigil Neuroscience to Present at Jefferies Inaugural Biotech..
2023/9/2620:05GLOBEVigil Neuroscience Receives Positive Opinion from European..
2023/9/1320:31EDGAR2Form 8-K - Current report
2023/9/1201:00GLOBEVigil Neuroscience Presents VGL101 Complete Phase 1 Data and..
2023/9/0905:10EDGAR2Form 8-K - Current report
2023/9/0905:05GLOBEVigil Neuroscience Announces Update on its Small Molecule..
2023/9/0820:05GLOBEVigil Neuroscience to Present at 2023 Morgan Stanley Global..
2023/8/0820:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0820:19EDGAR2Form 8-K - Current report
2023/8/0820:05GLOBEVigil Neuroscience Reports Second Quarter 2023 Financial..
2023/8/0807:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/8/0807:38EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/8/0805:05GLOBEVigil Neuroscience Appoints Christopher J. Silber, M.D. as..

最近閲覧した銘柄

Delayed Upgrade Clock